| Prev Close: | 32.53 |
|---|---|
| Open: | 32.73 |
| Bid: | 26.41 x 100 |
| Ask: | N/A |
| 1y Target Est: | 38.35 |
| Beta: | 1.35 |
| Next Earnings Date: | 29-Jul-13 |
| Day's Range: | 32.35 - 33.14 |
|---|---|
| 52wk Range: | 21.26 - 40.87 |
| Volume: | 381,696 |
| Avg Vol (3m): | 461,395 |
| Market Cap: | 1.31B |
| P/E (ttm): | 9.07 |
| EPS (ttm): | 3.63 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- ACORDA THERAPEUTICS INC FinancialsEDGAR Online Financials(Fri, May 17)
- Acorda Therapeutics’ Legal Department Recognized on Best Legal Departments List by Corporate Counsel MagazineBusiness Wire(Fri, May 17)
- Acorda Therapeutics to Present at the UBS Global Healthcare ConferenceBusiness Wire(Wed, May 15)
- ACORDA THERAPEUTICS INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri, May 10)
- Acorda says data support initiation of current dalfampridine development programtheflyonthewall.com(Thu, May 9)
- Acorda Therapeutics to Present at the Bank of America Merrill Lynch 2013 Health Care ConferenceBusiness Wire(Thu, May 9)
- Acorda Therapeutics Announces Data Showing Dalfampridine Improves Motor Function in Preclinical Model of Post-Stroke Deficits Published in StrokeBusiness Wire(Thu, May 9)
- ACORDA THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Thu, May 9)
- Acorda Incurs Loss, Maintains GuidanceZacks(Mon, May 6)
- Acorda Therapeutics Recognized as One of the Best Places to Work in New York State for Third Consecutive YearBusiness Wire(Mon, May 6)
- Investors are Digesting These Healthcare Stock Earnings Insightsat Wall St. Cheat Sheet(Sat, May 4)
- Acorda Therapeutics Earnings: Here’s Why Shares are Down Nowat Wall St. Cheat Sheet(Thu, May 2)
- Acorda Therapeutics, Inc. Earnings Call scheduled for 8:30 am ET todayCCBN(Thu, May 2)
- Acorda Therapeutics downgraded by MKM PartnersBriefing.com(Thu, May 2)
- Q1 2013 Acorda Therapeutics, Inc. Earnings Release - Before Market OpenCCBN(Thu, May 2)
Press Releases
- Acorda Therapeutics’ Legal Department Recognized on Best Legal Departments List by Corporate Counsel MagazineBusiness Wire(Fri, May 17)
- Acorda Therapeutics to Present at the UBS Global Healthcare ConferenceBusiness Wire(Wed, May 15)
Reports
- ACOR - Acorda Therapeutics Inc - Rated a Hold - Company Analysis and ASR Ranking...Alpha Street Research(May 21)
- ACORDA THERAPTUTICS INC (ACOR) - REPORT FOR ACTIVE TRADERSPechala's Reports(May 20)
- Trading Report for (ACOR). A detailed report, including free correlated market...Stock Traders Daily(May 19)